Omega Healthcare Investors, Inc. $OHI Shares Acquired by Bayforest Capital Ltd

Bayforest Capital Ltd boosted its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 395.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,129 shares of the real estate investment trust’s stock after purchasing an additional 901 shares during the period. Bayforest Capital Ltd’s holdings in Omega Healthcare Investors were worth $41,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in OHI. MassMutual Private Wealth & Trust FSB lifted its stake in Omega Healthcare Investors by 562.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock valued at $67,000 after purchasing an additional 1,552 shares during the last quarter. Register Financial Advisors LLC purchased a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at approximately $73,000. Trust Co. of Vermont purchased a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at approximately $95,000. Meeder Asset Management Inc. lifted its position in shares of Omega Healthcare Investors by 1,581.3% in the 1st quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust’s stock valued at $96,000 after acquiring an additional 2,372 shares in the last quarter. Finally, UMB Bank n.a. lifted its position in shares of Omega Healthcare Investors by 22.9% in the 2nd quarter. UMB Bank n.a. now owns 2,672 shares of the real estate investment trust’s stock valued at $98,000 after acquiring an additional 497 shares in the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on OHI. Mizuho upped their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a research report on Wednesday, August 27th. Raymond James Financial restated an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Scotiabank upped their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, August 28th. Finally, Cantor Fitzgerald began coverage on shares of Omega Healthcare Investors in a research report on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 price target for the company. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $44.38.

Omega Healthcare Investors Stock Up 1.8%

Omega Healthcare Investors stock opened at $41.07 on Friday. The firm has a market cap of $12.12 billion, a PE ratio of 25.35, a P/E/G ratio of 1.92 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. The firm’s 50 day moving average price is $41.58 and its two-hundred day moving average price is $38.89. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.32. The firm had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.5%. Omega Healthcare Investors’s dividend payout ratio is 165.43%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.